Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Y H Zhao
Observed name:
Yang Zhao
Institutions:
Second Hospital of Tianjin Medical University,
Tianjin Medical University
Observed institutions:
Second Hospital of Tianjin Medical University,
Tianjin Medical University
ORCID:
0000-0003-4656-172X
Observed ORCID:
0000-0003-4656-172X
OpenAlex ID:
A5130248276
Engineering MnPt Bimetallic Nanozymes for Cascade Enzymatic Therapy and Enhanced Radio‐Immunotherapy
2026
·
Wenyi Zhang
, Yangyang Guo
, et al.
·
Advanced Science
·
8
Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high‐risk, nonmuscle–invasive bladder cancer treated with tislelizumab plus nanoparticle albumin‐bound paclitaxel
2026
·
Shiwang Huang
, Kaipeng Jia
, et al.
·
Cancer
·
1
EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer
2026
·
Xiaomin Wang
, Yuhang Ding
, et al.
·
Frontiers in Pharmacology
·
1
PDF
MRI-guided nano-prodrug with self-detoxifying bioclearance for precision detection and therapy of cancer metastases
2026
·
Wenyi Zhang
, Dengyi Duan
, et al.
·
Chemical Engineering Journal
Biomimetic Phytic Acid–Metal–Albumin Nanocomplexes for Tumor-Selective, Bioclearable Theranostics
2026
·
Dengyi Duan
, Jing Peng
, et al.
·
ACS Nano Medicine
An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer
2026
·
Xiyao Zhang
, Miao Cao
, et al.
·
Discover Oncology
PDF
Correction: EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer
2026
·
Xiaomin Wang
, Yuhang Ding
, et al.
·
Frontiers in Pharmacology
PDF
Integration of a glutamine metabolism-based prognostic signature and a synergistic nanotherapeutic strategy targeting metabolic vulnerabilities in prostate cancer
2026
·
Wenya Li
, Weiying Ge
, et al.
·
Discover Oncology
[Mutation characteristics and prognosis of patients with Fanconi anemia signaling pathway gene mutation myeloproliferative neoplasm].
2026
·
Y H Zhang
, G S Teng
, et al.
·
PubMed
Show more works
View as search
Works count:
9
Citation count:
10
H-index:
1
I10-index:
Year
Topic
Type